Introduction The risk of infections associated with biological drugs (BD) and Janus kinase
inhibitors (JAKi) has been extensively explored in the literature. However, there is a dearth …

Background Patients with inflammatory bowel disease (IBD) are at increased risk of
infection. The aim of this study was to assess the cumulative incidence and risk of infection …

Background Recently, it has been questioned whether vaccination of patients with
inflammatory (auto) immune diseases under anti‐tumor necrosis factor (TNF) treatment …

The multicenter, retrospective cohort study was aimed at examining adverse events in
biologic-treated patients with moderate-to-severe psoriasis by using a real-world database …

Importance Laboratory testing for the presence of tuberculosis, hepatitis, and other
conditions before starting most systemic immunomodulatory agents is recommended in …

Background Vitiligo is an autoimmune disease, characterized by specific destruction of
melanocytes. While associations with numerous comorbid conditions, which potentially …

Psoriasis can have a significant impact on quality of life and productivity, especially with
increased severity. However, there is limited evidence on biologics' efficacy in highly severe …

Interleukins (ILs) are vital in regulating the immune system, enabling to combat fungal
diseases like candidiasis effectively. Their inhibition may cause enhanced susceptibility to …

In this issue of JAMA Dermatology, Schneeweiss et al1 present an article examining
laboratory screening and monitoring patterns in treating patients with chronic inflammatory …

Psoriasis is a chronic, immunologically mediated disease of multifactorial origin, with genes
playing a key role and environmental factors, such as infections, often triggering its onset or …